van Wezel H B, Bovill J G, Visser C A, Koolen J J, Janse M J, Meijne N G, Barendse G A, Floor L M, Djamin R
Department of Anesthesiology, Academisch Medisch Centrum, Amsterdam, The Netherlands.
J Cardiothorac Anesth. 1987 Oct;1(5):408-17. doi: 10.1016/s0888-6296(87)96860-8.
The effects of nitroprusside and nifedipine on myocardial oxygen consumption (MVO2), catecholamine release, and left ventricular (LV) function (using 2D transesophageal echocardiography) were compared. Thirty-seven patients undergoing coronary artery surgery, anesthetized with fentanyl, 100 micrograms/kg, were studied. All had good LV function and had been receiving long-term oral beta-blocking therapy. Patients were randomly allocated to one of three groups. Group C (n = 12) received no vasodilator and served as control. Group S (n = 13) received nitroprusside at an initial rate of 1 microgram/kg/min. Group N (n = 12) received nifedipine at an initial rate of 0.7 microgram/kg/min. Baseline measurements were obtained ten minutes after intubation. Vasodilator therapy was then started in groups S and N. Infusion rates were adjusted to maintain systolic blood pressure (SBP) between 80% and 120% of baseline values. Additional measurements were made ten minutes after the start of the infusion, ie, before surgery (in group C immediately before surgery), and after sternotomy when the pericardium was opened. The mean (+/- SD) total dose requirements were 1.9 +/- 0.5 micrograms/kg/min for nitroprusside and 1.1 +/- 0.2 micrograms/kg/min for nifedipine. The mean (+/- SD) total infusion time was 31 +/- 5 minutes for nitroprusside and 32 +/- 11 minutes for nifedipine. After sternotomy, heart rate increased in all groups. At this time arterial blood pressure and systemic vascular resistance (SVR) increased in group C. SVR was decreased after the first ten minutes of nitroprusside infusion and after sternotomy in group S. Coronary sinus blood flow, MVO2, and myocardial norepinephrine release increased in group N, but not in groups C or S. After sternotomy, LV percentage area reduction increased in groups S and N, but not in group C. In group N there was a significant correlation (r = 0.65; P less than .05) between the increases in MVO2 and LV percentage area reduction, an estimate of myocardial function. Lactate production occurred in two patients in group C after sternotomy. This was not associated with ECG changes, but in one patient regional wall motion abnormalities developed. No evidence of myocardial ischemia was observed in groups S and N. However, in contrast to nitroprusside, the use of nifedipine was associated with increases in MVO2, myocardial norepinephrine release, and inotropy.
比较了硝普钠和硝苯地平对心肌耗氧量(MVO2)、儿茶酚胺释放及左心室(LV)功能(采用二维经食管超声心动图)的影响。对37例行冠状动脉手术、用100微克/千克芬太尼麻醉的患者进行了研究。所有患者左心室功能良好且一直在接受长期口服β受体阻滞剂治疗。患者被随机分为三组。C组(n = 12)未接受血管扩张剂,作为对照组。S组(n = 13)以1微克/千克/分钟的初始速率接受硝普钠治疗。N组(n = 12)以0.7微克/千克/分钟的初始速率接受硝苯地平治疗。插管后10分钟获取基线测量值。然后S组和N组开始血管扩张剂治疗。调整输注速率以维持收缩压(SBP)在基线值的80%至120%之间。在输注开始后10分钟、即手术前(C组在手术前即刻)以及胸骨切开打开心包后进行额外测量。硝普钠的平均(±标准差)总剂量需求为1.9±0.5微克/千克/分钟,硝苯地平为1.1±0.2微克/千克/分钟。硝普钠的平均(±标准差)总输注时间为31±5分钟,硝苯地平为32±11分钟。胸骨切开后,所有组的心率均增加。此时,C组的动脉血压和体循环血管阻力(SVR)升高。硝普钠输注最初10分钟后及S组胸骨切开后SVR降低。N组的冠状窦血流量、MVO2和心肌去甲肾上腺素释放增加,而C组和S组未增加。胸骨切开后,S组和N组的左心室面积缩小百分比增加,C组未增加。在N组中,MVO2的增加与左心室面积缩小百分比(心肌功能的一项指标)的增加之间存在显著相关性(r = 0.65;P <.05)。胸骨切开后,C组有两名患者出现乳酸生成。这与心电图变化无关,但有一名患者出现了局部室壁运动异常。S组和N组未观察到心肌缺血的证据。然而,与硝普钠不同,使用硝苯地平与MVO2增加、心肌去甲肾上腺素释放增加及心肌收缩力增强有关。